Category: Digital Health

Kapa3 partners with PRAXI Network (FORTH) to boost international networking and access to European funding opportunities

The Cancer Guidance Center – Kapa3 announces its partnership with the PRAXI Network of the Foundation for Research and Technology – Hellas (FORTH), within the framework of the European Digital Innovation Hub smartHEALTH: European Digital Innovation Hub for Smart Health – Precision Medicine and Innovative e-Health Services.

This collaboration is part of the broader Digital Europe Programme 2021–2027 and aims to strengthen Kapa3’s participation in research, innovation, and health policy initiatives, focusing on improving services and enhancing the quality of life of oncology patients.

Within this partnership, Kapa3 will receive substantial support in identifying and leveraging funding opportunities through systematic information and expert guidance on available programmes at European, national, and regional level, including Horizon Europe, EU4Health, Erasmus+, and EIT Health. At the same time, its capacity to actively participate in competitive proposals and collaborative projects will be reinforced, expanding its potential to develop innovative initiatives in the health sector.

Particular emphasis is also placed on the development of strategic partnerships with universities, research centres, and healthcare organisations across Europe. Through targeted support in partner identification and the exploration of synergies, Kapa3 strengthens its position within the European research and innovation ecosystem, creating opportunities for participation in international consortia.

In parallel, the collaboration contributes to enhancing the organisation’s international presence and networking capacity through participation in thematic conferences, brokerage events, and matchmaking initiatives in the fields of public health, digital health, social innovation, and patient-centred care.

This Kapa3 PRAXI Network partnership is expected to act as a catalyst for strengthening Kapa3’s outward-looking orientation and sustainable development, reinforcing its role as an active and dynamic stakeholder in the field of health and patient support at both national and European level.

The support services are provided within the smartHEALTH framework and are co-funded by European and national resources.

The Founding Sponsor of the “Myrto”Health Navigator is the TIMA Foundation.

Press release source: PRESS-RELEASE-PRAXI-Network-–-FORTH

Text/adaptation: Ifiyenia Anastasiou for Kapa3

Kapa3 announces collaboration with SimasiaAI for the development of the Health Navigator “Myrto” (Myrto AI Assistant)

The Kapa3 – Cancer Guidance Center announces its collaboration with SimasiaAI, for the co-development of the Health Navigator “Myrto” (Myrto AI Assistant), an artificial intelligence (AI chatbot) designed to enhance digital cancer support for patients with cancer and their families through immediate, reliable, and personalized information.

This initiative is part of Kapa3’s strategic focus on leveraging innovative digital tools to improve access to information, strengthen guidance, and reduce the digital gap often faced by vulnerable groups in the healthcare sector.

The Health Navigator “Myrto” is not just an information tool, but a new form of social artificial intelligence in cancer care support in Greece. It is designed to transform digital information into a more human, accessible, and meaningful experience, allowing users to interact, receive guidance, and access support tailored to their needs.

Through its dual role as a “Patient Empowerment e-Navigator”, the system will function both as a Patient Advocate—providing guidance on patient rights, benefits, and access to healthcare and social services—and as a Health Navigator, offering reliable information to support better understanding and self-management of health-related issues.

At the same time, the Health Navigator “Myrto” aims to enhance health literacy, support the psychosocial dimension of the disease, and highlight available community resources, contributing to the reduction of inequalities in access to information.

Kapa3, with its long-standing experience in guiding and supporting cancer patients, continues to invest in initiatives that promote equal access to information and digital empowerment, utilizing technology with a strong social and human-centered approach.

The collaboration between Kapa3 and SimasiaAI leads to the development and integration of the Health Navigator “Myrto” into Kapa3’s platform, highlighting the importance of cooperation between social organizations and technology providers in creating innovative digital support tools for cancer patients. Through this initiative, the goal is to meaningfully empower patients, support healthcare professionals, and advance more human-centered digital services.

The development of the Health Navigator “Myrto” marks an important step toward a new model of digital care, where artificial intelligence complements human support, enhancing the quality of life of patients and their families.

The Founding Sponsor of the “Myrto”Health Navigator is the TIMA Foundation.

Our Press Release text here: PRESS RELEASE SIMASIA AI

Text: Ifiyenia Anastasiou for Kapa3

New National Patient Registry for Hospital-at-Home Care (NOSPI)

Patient care at home in Greece is becoming more organized and secure with the establishment of the National Registry of Patients Receiving Hospital-at-Home Care (NOSPI), as published in Government Gazette 1995/07.04.2026. The NOSPI program is already in pilot implementation at selected hospitals nationwide, with the goal of full development and operation by the end of 2026, including a digital platform and patient registry.

The new registry aims to systematically record patients receiving NOSPI services, ensuring that care is tailored to individual therapeutic needs. Patient groups eligible for inclusion include, among others, those with tracheostomies, on non-invasive mechanical ventilation, receiving long-term oxygen therapy, on parenteral or gastrostomy feeding, as well as those requiring intensive physiotherapy or mobility rehabilitation. Currently, enrollment primarily focuses on children with severe health conditions and chronically ill patients needing pulmonary care, in collaboration with pilot Reference Centers.

While the NOSPI program is already operating in a pilot phase, universal access for all patients in the country has not yet been achieved. Its development is gradual, with full operation—including digital infrastructure and registry-based documentation—planned by the end of 2026. Strengthening Hospital-at-Home care enables better monitoring and improvement of home care services for patients with long-term needs.

Through the registry, authorities can collect accurate and essential health data, enhancing the quality of services and supporting the design of targeted health policies. Implementation respects personal data protection in line with the General Data Protection Regulation (GDPR), ensuring transparency and public trust.

For families and caregivers, patient enrollment in the NOSPI National Registry means access to more coordinated care, with support delivered directly to their homes. Furthermore, documentation helps evaluate and improve home nursing services, enhancing patient safety and quality of life.

This initiative, combined with the development of the digital platform and registry, aims not only to upgrade home care services but also to reduce hospital congestion and ensure high-quality services for all patients in the future.

Sources (text in Greek) : Government Gazette NOSPI, ODIPY

Text/adaptation: Ifiyenia Anastasiou for Kapa3

Expansion of High-Cost Medicines Available Through EOPYY Private Pharmacies – What Changes for Patients

The Hellenic National Organization for the Provision of Health Services (EOPYY) is expanding the list of new high-cost medicines available through private EOPYY pharmacies, facilitating patient access to high-cost treatments. The recent decision was published in the Government Gazette.

This development represents another step toward simplifying patient access to high-cost therapies, reducing the need for physical visits to EOPYY pharmacies.

The new regulation includes the addition of further medicines, broadening the scope of the measure. Among these are treatments for multiple sclerosis, such as the active substance ocrelizumab, as well as anticancer agents like imatinib and capecitabine, widely used in oncology. This expansion is expected to significantly benefit more patients, who until now had to be served through specific distribution points, often facing longer waiting times. Patients will gain convenience and improved continuity of care, as access to treatments becomes faster and more reliable.

The option to collect medicines from private EOPYY pharmacies is expected to substantially improve patients’ daily lives, reducing hassle and enhancing accessibility, especially for those with chronic or serious conditions. This change is also part of the broader digital transformation of health services, aiming for a more flexible and patient-centered system. Healthcare providers will be able to monitor medicine distribution more efficiently, ensuring timely support and guidance for patients throughout their treatment.

According to the Government Gazette:

The start date of the medicine distribution process, with supply by EOPYY and final delivery at the private pharmacy specified in ministerial decision EΑLE/GΠ/oικ.51724/19-11-2025, as listed in the table below, is set as the date when EOPYY’s upgraded electronic platform (fyk.eopyy.gov.gr) becomes fully operational for the submission of patient requests under the new procedure defined in the above ministerial decision.

You can read the Government Gazette here (greek text)

Read our previous articles on the HCM procedure here and here

Text/Adaptation: Ifiyenia Anastasiou for Kapa3

Kapa3 joins the Hellenic Digital Health Cluster (HDHC)

The Cancer Patient Guidance Center – Kapa3 is pleased to announce its participation in the Hellenic Digital Health Cluster (HDHC), strengthening its connection with the Greek digital health ecosystem.

The Kapa3 HDHC collaboration marks the organization’s active integration into a dynamic innovation network. Through this partnership, Kapa3 gains access to a network of 47 innovative organizations, as well as the Foundation for Research and Technology – Hellas (FORTH), aiming to enhance the quality of support services for cancer patients.

The HDHC brings together and connects leading organizations, businesses, and research institutions in the field of digital health in Greece, providing a framework for networking, collaborations, and innovative projects, as well as access to funding and investment opportunities. Its mission is to empower the Greek digital health ecosystem, with the goal of positioning Greece among the leading countries in the sector internationally within the next decade.

Through its participation in HDHC, Kapa3 further strengthens its mission to support cancer patients by adopting modern, technology-driven approaches and innovative practices. As a member, the organization gains the opportunity to take part in events, working groups, and collaborative initiatives, while fostering the exchange of knowledge and expertise with other stakeholders in the ecosystem.

At the same time, this participation creates opportunities for Kapa3 to actively contribute to the development of a sustainable and forward-looking digital health ecosystem in Greece, promoting collaboration, innovation, and shared perspectives towards institutional strengthening of the sector. It also provides access to emerging technologies and best practices that can improve patient experience and enhance the effectiveness of care services.

Through this collaboration, Kapa3 reinforces its role as an organization that connects cancer patient support with the ongoing developments in digital health in Greece and internationally, building bridges between care, technology, and innovation for the community it serves.

You can download our Press Release here 

Text: Ifiyenia Anastasiou for Kapa3

Kapa3 in the First Half of March: Actions, Collaborations, and Updates for Oncology Patients

During the first half of March, Kapa3 continued to highlight important topics concerning the oncology patient support, rights, and daily lives  through initiatives, collaborations, and informational activities.

Efforts focused both on strengthening access to information and services, and on promoting practical and digital tools that make patients’ daily lives easier.

In an environment where patients’ needs remain complex and constantly evolving, reliable information, enhanced collaboration among stakeholders, and the promotion of holistic care are especially important.

Below is a summary of the main developments from the month.

Collaborations

Key partnerships were strengthened with the Sarcoma Fighters Patients Association, the Hellenic Federation of Persons with Multiple Sclerosis (HFoPwMS), and Doctor Homie, aiming to enhance information, support, and quality care for patients.

Actions & Presentations

Kapa3 participated in the scientific meeting “Cancer in 2026: Challenges and Breakthroughs,” emphasizing the pivotal role of supportive care for oncology patients, while also presenting recent developments addressing their evolving needs. Kapa3 also attented the event “Facing the Challenge of Artificial Intelligence” as we remain focused on supporting dialogue around the opportunities and challenges of A.I.

Patient Rights

Supporting oncology patients remains a central goal of our initiatives. Focus was given to updates on the 2026 constant attendance allowance and improved digital access for patients to their test results.

Digital Health & Research

A new European Commission report highlights the critical role of digital health technologies in transforming healthcare systems, outlining both opportunities and challenges for the future of care.

Awareness

March is Colorectal Cancer Awareness Month, reminding everyone of the importance of prevention and early detection.

Oncology patient support remains our top priority, and we continue to monitor developments — more news will follow.

Kapa3’s Contribution to the 6th Nursing Symposium of Western Macedonia: Digital Health, Empathy, and Patient Navigation

With active participation in a well-established scientific meeting on contemporary nursing issues, Kapa3 took part in the 6th Nursing Symposium of Western Macedonia on “Innovation and Empathy: Balancing Technology with Human Contact in Nursing”, held on March 19–20, 2026, in Ptolemaida.

The Symposium, now a key annual event for the nursing community, serves as a platform for dialogue, knowledge exchange, and highlighting the multifaceted role of nurses in modern healthcare.

As part of the thematic session “Innovation and Citizen Engagement: Creating Accessible Tools with Empathy”, Ms. Evangeli Bista, co-founder of Kapa3, joined the panel along with Ms. Pisti Krystallidou, President of the NGO WinCancer, showcasing the role of civil society in shaping contemporary, accessible healthcare services.

On March 20, Ms. Evangeli Bista and Ms. Pisti Krystallidou actively participated in the Round Table on the same theme. Ms. Krystallidou presented “Empathy in Practice: What the Caregiver Gains from Health Professionals”, highlighting the daily challenges and support needs of people caring for patients. Ms. Bista emphasized Kapa3’s role and the use of digital tools in guiding patients effectively.

During her presentation, Ms. Bista outlined how the healthcare system is transforming: from episodic care to continuous support, from hospital-centered services to daily-life integration, and from the healthcare professional as the sole source of knowledge to the patient as an active participant. In this new environment, digital health and patient navigation go beyond mere tools, focusing on the citizen’s ability to use them meaningfully in everyday life.

Special attention was given to the needs of oncology patients, who require not only access to information but also guidance through a complex healthcare system—knowing where to turn, what they are entitled to, and how to manage critical decisions in daily life. In this context, the importance of patient navigation was highlighted, a model that Kapa3 has implemented since its foundation, acting as a bridge between available services and patients’ real needs.

Finally, the digital social assistant “Myrto” was presented, serving as a single reference point for patients, facilitating access to information and services, and translating knowledge into practical, everyday support.

Kapa3’s participation in the Symposium highlighted the importance of combining technological innovation with empathy, confirming that the future of oncology care is not only about personalized treatment but also about personalized understanding of each patient’s needs.

Download our Press Release here 

Text/Adaptation: Ifiyenia Anastasiou for Kapa3

Digital Access to Test Results: An Important Right for Patients

Digital access to medical test results has become an important right for patients in Greece, following new regulations that strengthen the use of the Digital Repository of Diagnostic Laboratory Results. According to the relevant decision published in the Government Gazette (March 2026), public and private healthcare units collaborating with EOPYY are required to record diagnostic test results in digital form within a specified timeframe.

This change is not just a technical procedure or an administrative obligation for healthcare providers. In practice, it represents a meaningful enhancement of patients’ rights, ensuring that every citizen can have immediate and organized access to their medical data.

Digital access to test results now reduces the need for physical documents, printed copies, or trips to diagnostic centers. Instead, results are stored in a unified digital environment connected to the Individual Electronic Health Record. This allows patients to have their test history consolidated, reducing the risk of losing important information.

For people living with cancer, this development is especially significant. Disease monitoring often involves repeated tests, visits to different doctors, and continuous evaluation of results. Immediate access to all data facilitates collaboration among healthcare professionals and contributes to more coordinated and effective care.

Moreover, the obligation to record results is linked to reimbursement procedures through EOPYY, enhancing transparency in the healthcare system. This ensures that only tests that have actually been performed are reimbursed, limiting abuse and strengthening the reliability of services.

It is also worth noting that data management is carried out under the current personal data protection framework, safeguarding patients’ privacy and information security.

Transitioning to a more digital healthcare system is not just a technological advancement. It is a step toward a more human, transparent, and accessible system of care, where the patient has an active role and meaningful control over their own data.

Ultimately, strengthening digital access to test results represents an important step forward in empowering patients and improving the quality of healthcare provided.

Source: Government Gazette, FEK B’ 1503/17.03.2026

Text/adaptation: Ifiyenia Anastasiou for Kapa3

Digital Health Technologies in Europe: New European Commission Report Highlights Opportunities and Challenges

Digital health technologies in Europe are a key pillar in transforming care systems, as highlighted in the new European Commission report (published in 2026), titled “Observatory for Digital Health Technologies in Europe”. The report, prepared for the Directorate-General CONNECT (DG CNECT) by Capgemini Invent and IDC, provides a comprehensive overview of the EU27 digital health market, analyzing both the technology ecosystem and its economic impact.

The report is structured in three main sections. The first focuses on the creation of the Digital Health Technologies Observatory, a strategic tool for monitoring adoption, innovation, and investment in the sector. The second part presents the economic analysis of five selected technologies, while the third contains conclusions and policy recommendations.

The analysis draws on extensive data, including pan-European surveys of healthcare providers and technology companies, expert interviews, mapping of hundreds of providers, and analysis of tens of thousands of investment records. The findings depict a rapidly growing yet fragmented digital health market in Europe.

Artificial intelligence plays a central role in this transformation, with 94% of healthcare providers already adopting or planning to integrate it. Technologies such as Clinical Decision Support Systems (CDSS), automated medical imaging analysis, and digital mental health platforms are highlighted as particularly important for improving care quality and enhancing health system efficiency.

The economic benefits are substantial. CDSS are estimated to enable savings of up to €252 billion over a decade, while automated medical imaging analysis could save up to €192 billion. Similarly, digital mental health platforms support early intervention and reduce the burden on healthcare services, providing significant social and economic benefits.

The report also identifies critical challenges, such as market fragmentation, interoperability issues, and dependence on non-EU providers in strategic areas. Additionally, issues related to digital skills, regulatory frameworks, and equitable access continue to affect the widespread adoption of these technologies.

To address these challenges, the report recommends measures such as strengthening interoperability, supporting small and medium-sized enterprises, promoting innovation in cutting-edge fields (such as AI and genomics), and integrating principles of sustainability, accessibility, and equity.

The positioning of digital health technologies in Europe as a key pillar for the future of care systems is closely linked with initiatives developed at the national level. In this context, Kapa3 invests in digital tools that enhance information, accessibility, and empowerment of oncology patients, such as the “Myrto” Health Navigator. You can read more about it here.

As Europe seeks to build a more resilient and inclusive health system, leveraging digital technologies emerges as a decisive factor in improving patient quality of life and the effectiveness of healthcare services.

Sources:

Text/Adaptation: Ifiyenia Anastasiou for Kapa3

Kapa3 Participation in the 3rd “Mapping the Unknown in Oncology” Conference

Kapa3 actively participated in the conference “Mapping the Unknown in Oncology – From Hospitals to Homes, mapping the future of oncology care”, organized for its third year by the Medical Society for Research and Education under the auspices of HeSMO (Hellenic Society of Medical Oncologists) and the Hellenic Cancer Society, held on February 27–28, 2026 at the Golden Age Hotel in Athens.

During the events on Saturday, February 28, Ms. Evangelí Bista, Head of Operations and Development at the Kapa3 Cancer Patient Guidance Center, took part in the panel titled “e-Health Tools and Educational Platforms: New Paths for Doctors and Patients.” The panel was moderated by Ms. Z. Saridaki and included panelists G. Koukourakis, S. Peroukidis, F. Tyligadas, and Ch. Christodoulou.

In her presentation, titled “Digital Patient Education: The Patient as an Active Partner,” Ms. Bista highlighted the importance of digital transformation in healthcare, which shifts care from episodic to continuous support, moving healthcare from hospitals into patients’ daily lives and empowering patients to become active participants in managing their health.

In this context, Kapa3 announced that for 2026 it will be the only civil society organization fully integrating AI, cybersecurity, and high-performance computing into its processes and services, implementing:

  • An AI-powered digital assistant (chatbot) for immediate patient guidance and support

  • A voice-command system for website accessibility and text-to-speech conversion

  • Service redesign, simplifying processes and reducing bureaucracy

  • An AI-based recommendation system with usage data analysis to personalize services

Special emphasis was placed on patient navigation, as oncology patients need guidance: where to go, what they are entitled to, when to be concerned, and when to wait. Kapa3 addresses this gap, providing not just information but meaningful, personalized guidance within the healthcare system.

The goal is not to add another service but to unite existing services. The next evolution of this model is Myrto, the digital assistant that serves as a reference point, translating knowledge into daily action.

Because the future of oncology is not only personalized treatment but also personalized understanding.

Kapa3’s participation underscores the organization’s commitment to innovation, collaboration, and ethics, demonstrating how technology can significantly enhance the experience and care of oncology patients.